Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, 13:00 - 14:00 Amsterdam time (CEST), from 14/07/2023 to 14/07/2023

Submitted by Anonymous (not verified) on 25 August 2023 - 8:14

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, 13:00 - 14:00 Amsterdam time (CEST), from 14/07/2023 to 14/07/2023

Opinion/decision on a Paediatric investigation plan (PIP): RoActemra,tocilizumab, decision type: , therapeutic area: , PIP number: P/0354/2022

Submitted by Anonymous (not verified) on 24 August 2023 - 14:10

Opinion/decision on a Paediatric investigation plan (PIP): RoActemra,tocilizumab, decision type: , therapeutic area: , PIP number: P/0354/2022

Human medicines European public assessment report (EPAR): Tolucombi, telmisartan,hydrochlorothiazide, Hypertension, Date of authorisation: 13/03/2013, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 24 August 2023 - 13:19

Human medicines European public assessment report (EPAR): Tolucombi, telmisartan,hydrochlorothiazide, Hypertension, Date of authorisation: 13/03/2013, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Dengue, Date of authorisation: 12/12/2018, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 23 August 2023 - 14:44

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Dengue, Date of authorisation: 12/12/2018, Revision: 5, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More